| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quince Therapeutics, Inc. | President | Common Shares | 130,009 | $156,010 | $1.20 | 18 Jun 2025 | Direct |
| Quince Therapeutics, Inc. | President | Warrants | 7,548 | $943 | $0.1250 | 18 Jun 2025 | Direct |
| Quince Therapeutics, Inc. | President | Employee Stock Option (right to buy) | 300,000 | 28 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | 18 Jun 2025 | 2 | +$10,001 | 4 | President | 23 Jun 2025, 08:46 |
| QNCX | Quince Therapeutics, Inc. | 28 Jan 2025 | 1 | $0 | 4 | PRESIDENT | 11 Feb 2025, 17:43 |
| QNCX | Quince Therapeutics, Inc. | 20 Aug 2024 | 1 | +$31,452 | 4 | PRESIDENT | 22 Aug 2024, 17:51 |
| QNCX | Quince Therapeutics, Inc. | 01 Feb 2024 | 1 | $0 | 4 | PRESIDENT | 02 Feb 2024, 18:02 |
| QNCX | Quince Therapeutics, Inc. | 01 Sep 2023 | 1 | $0 | 4 | President | 06 Sep 2023, 17:43 |
| QNCX | Quince Therapeutics, Inc. | 01 Sep 2023 | 0 | $0 | 3 | President | 06 Sep 2023, 17:40 |